Varying expression of neurotrophic factors in rat bone marrow stromal cells according to number of culture passages

Biotecnologia Aplicada

Volumn 27, Issue 4, 2010, Pages 281-285

  García, Rocío ^a   Pavoń, Nancy ^a   Vergara, Paula ^b   Segovia, José ^b   Alberti, Esteban ^a  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Bone marrow stromal cells; Immunocytochemistry; Neurotrophic factors; RT PCR; Western blot

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW STROMAL CELL; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CULTURE PASSAGE 12; CULTURE PASSAGE 7; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

RATTUS;

EID: 80053417593     PISSN: 08644551     EISSN: 10272852     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mezey E. Bone marrow-derived stem cells in neurological diseases: stones or masons? Regen Med 2007;2:37-49. (Pubitemid 46824411)
2. Zhang C, Li Y, Chen J, Gao Q, Zacharek A, Kapke A, et al. Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats. Neuroscience 2006;141:687-95. (Pubitemid 44066656)
3. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005;11:96-104. (Pubitemid 40012003)
4. Brodhun M, Bauer R, Patt S. Potential stem cell therapy and application in neurotrauma. Exp Toxicol Pathol 2004;56:103-12. (Pubitemid 39486852)
5. Pavón N, Blanco L, Martínez L, Castillo L, Cuétara K, García R, et al. Trasplante de células estromales en el modelo de lesión por 6-OHDA. Rev Neurol 2004;39:326- 34.
6. Calissano P, Matrone C, Amadoro G. Nerve Growth Factor as a paradigm of neurotrophins related to Alzheimer's Disease. Dev Neurobiol 2010;70:372-83.
7. Mínguez A, Escamilla F. Terapia celular y otras estrategias neurorregenerativas en la enfermedad de Parkinson (II). Rev Neurol 2005;41:684-93.
8. Landreth GE. Growth Factors. In: Siegel GJ, Albers RW, Brady ST, Price DL, editors. Basic neurochemistry. Molecular, cellular and medical aspects. 7th ed. Boston, Mass: Elsevier Academic Press: 2006, p. 471-84.
9. Yoshii A, Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 2010;70:304-22.
10. Barroso-Chinea P, Cruz-Muros I, Aymerich M, Rodríguez-Díaz M, Afonso- Oramas D, Lanciego J, et al. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. Eur J Neurosci 2005;21:1815-27. (Pubitemid 40685862)
11. Hurelbrink C, Barker R. The potential of GDNF as a treatment for Parkinson's disease. Exp Neurol 2004;185:1-6. (Pubitemid 38010273)
12. Kordower J. In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease. Ann Neurol 2003; 53:S120-34. (Pubitemid 36368568)
13. Yang K, Yuan X, Sun J, Long Y, Lai EC. Bone marrow stromal cell as potential cellular therapy for treatment of Parkinson's disease. Mov Disord 2002;17 Suppl. 5:18.
14. Yamaguchi S, Kuroda S, Kobayashi H, Shichinohe H, Yano S, Hida K, et al. The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC)-a preliminary study using microarray analysis. Brain Res 2006;1087:15-27. (Pubitemid 43783157)
15. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005;195:16-26. (Pubitemid 41116810)
16. García R, Aguiar J, Alberti E, Cuétara K, Pavón N. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun 2004;316:753-4. (Pubitemid 38368017)
17. Garcia-Tovar CG, Perez A, Luna J. Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp71f) in rat brain. Acta Histochem 2001;103:209-24. (Pubitemid 32385679)
18. Sekiya I, Larson B, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002;20:530-41. (Pubitemid 35463066)
19. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 2001;3:393-6. (Pubitemid 34784633)
20. Colter D, Class R, DiGirolamo C, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000;97:3213-8. (Pubitemid 30183281)
21. Gregory C, Prockop D, Spees J. Nonhematopoietic bone marrow stem cells: Molecular control of expansion and differentiation. Exp Cell Res 2005;306(2):330-5. (Pubitemid 40732757)
22. Yaghoobi MMY, Mowla SJ. Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neurosci Lett 2006;397:149-54. (Pubitemid 43340477)
23. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-8. (Pubitemid 38268957)
24. Ylostalo J, Bazhanov N, Prockop D. Reversible commitment to differentiation by human multipotent stromal cells (MSCs) in single-cell derived colonies. Exp Hematol 2008;36:1390-402.
25. Leßmann V, Brigadski T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update. Neurosci Res 2009;65:11-22.
26. Barker PA. Whither proBDNF? Nat Neurosci 2009;12:105-6.
27. Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, et al. Environmental enrichment rescues protein deficits in a mouse model of Huntington's Disease, indicating a possible disease mechanism. J Neurosci 2004; 24:2270-6. (Pubitemid 38314558)
28. Yang J, Siao C- J, Nagappan G, Marinic T, Jing D, McGrath K, et al. Neuronal release of proBDNF. Nat Neurosci 2009;12:113-5.
29. Ye M, Chen S, Wang X, Qi C, Lu G, Liang L, et al. Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat. Neuroreport 2005;16:581-4. (Pubitemid 40586087)
30. Gregory C, Ylostalo J, Prockop DJ. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by micro-environmental niches in culture: a two-stage hypothesis for regulation of MSC fate. Sci STKE 2005;2005(294):pe37.
31. Katoh-Semba R, Tsuzuki M, Yoshida A, Nakajima H, Kitajima C, Matsuda M. Distribution and immunohistochemical localization of GDNF protein in selected neural and non-neural tissues of rats during development and changes in unilateral 6-hydroxydopamine lesions. Neurosci Res 2009;59:277-87. (Pubitemid 47503377)
32. Moretto G, Walker DG, Lanteri P, Taioli F, Zaffagnini S, Xu RY, et al. Expression and regulation of glial-cell-line-derived neurotrophic factor (GDNF) mRNA in human astrocytes in vitro. Cell Tissue Res 1996;286:257-62. (Pubitemid 26383673)
33. Morís G, Vega J. Factores neurotróficos: Fundamentos para su aplicación clínica. Neurología 2003;18(1):18-28. (Pubitemid 36288033)